Jade Biosciences, Inc. cotiza a 13.42 USD y tiene una capitalización bursátil de $853M. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Jade Biosciences, Inc. operates as a biotechnology company that develops therapies for inflammation and immunology indications in patients living with autoimmune diseases. It develops JADE101, a monoclonal antibody to block the A PRoliferation Inducing Ligand protein, which is in phase 1 clinical trial. The company als…
| Métrica | JBIO | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | — | 57.0% | — |
| Operating Margin | — | -38.6% | — |
| Net Margin | — | -33.6% | — |
| FCF Margin | — | -13.9% | — |
| ROE | -38.3% | -40.4% | +2.1% |
| ROA | -36.4% | -32.0% | -4.4% |
| Current Ratio | 21.09 | 2.84 | +18.25 |
| Debt / Equity | — | 0.28 | — |